Applied Therapeutics, Inc.

APLT

Applied Therapeutics, Inc.

APLT

Insider Sentiment (TTM):

Last Purchase:2023-12-01Last Sale:2025-12-16Shares Purchased (TTM):0Shares Sold (TTM):43,000

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:36,482,594Shares Outstanding:145,559,604Institutional Ownership Pct.:25.06%

Earnings Market Reaction:

Filing Date:2025-11-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Applied Therapeutics, Inc. (APLT) — SEC Financial Statements & Analysis

Applied Therapeutics, Inc. (APLT) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	12	30	51	79	99	122	146	50	37	36	23	17
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	14
Prepaid Expense And Other Assets Current	20	4	3	4	5	5	4	4	7	7	6	7
Assets Current	32	35	54	84	105	128	151	54	44	43	29	37
Operating Lease Right Of Use Asset	2	3	3	3	2	0	0	0	1	1	1	1
Assets	34	37	57	87	107	128	151	55	45	44	30	38
Liabilities And Stockhold…
Liabilities Current
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Payable Current	5	5	5	4	3	3	4	2	6	5	6	5
Liabilities Current	33	18	18	27	99	55	84	71	56	47	33	33
Liabilities Noncurrent
Operating Lease Liability Noncurrent	2	2	2	2	2	0	0	0	0	0	0	0
Liabilities Noncurrent	2	2	2	2	2	0	0	1	1	1	1	1
Liabilities	35	20	20	30	101	55	84	72	56	48	34	34
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Value	-	-	-	0	-	-	-	0	-	-	-	-
Additional Paid In Capital	636	635	633	631	624	622	620	451	420	384	355	353
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	-	-	-	-	-	0
Retained Earnings Accumulated Deficit	-636	-617	-596	-574	-618	-550	-553	-469	-431	-389	-359	-349
Stockholders Equity	-1	17	37	57	6	72	67	-17	-11	-4	-4	4
Liabilities And Stockholders Equity	34	37	57	87	107	128	151	55	45	44	30	38
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	250	250	250	250	250	250	200	200	200	200	200	200
Common Stock Shares Issued	144	142	142	137	116	115	114	85	77	62	48	48
Shares Outstanding	144	142	142	137	116	115	114	85	77	62	48	48
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	-23.92%	-34.02%	-9.07%	4.87%	121.24%	154.42%	-19.63%	-61.85%	-61.85%	-	-	-
2024	-7.36%	1.08%	12.99%	2.26%	33.39%	35.97%	-79.16%	-91.24%	-93.44%	21.95%	12.50%	-2.44%
2023	-18.18%	-22.42%	-9.70%	-16.56%	58.60%	66.24%	16.91%	61.84%	40.58%	5.26%	-33.75%	-36.84%
2022	-	-	-	-	-	-	-	-	-	-0.48%	89.29%	75.00%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	0.96	1.94	3.00	3.06	1.06	2.30	1.80	0.76	0.80	0.91	0.87	1.12
Quick Ratio	0.36	1.71	2.83	2.91	1.00	2.21	1.75	0.70	0.67	0.75	0.69	0.92
Working Capital	-1.25M	16.76M	36.00M	56.35M	5.64M	72.22M	67.00M	-16.80M	-11.02M	-4.37M	-4.19M	3.88M
Leverage & Debt
Debt to Equity	-62.27	1.14	0.55	0.52	17.09	0.77	1.25	-4.20	-5.09	-11.07	-8.37	8.45
Interest Coverage TTM	-47.04	-33.70	-30.47	-29.51	-31.58	-39.87	-43.05	-47.04	-48.38	-58.88	-85.19	-121.09
Debt Ratio	1.02	0.53	0.36	0.34	0.94	0.43	0.56	1.31	1.24	1.10	1.14	0.89
Efficiency & Turnover
Asset Turnover TTM	0.01	0.00	0.00	0.01	-0.00	-0.00	-0.01	0.21	0.21	0.18	0.22	0.00
Per Share Metrics
Diluted EPS TTM	-0.12	-0.47	-0.30	-0.76	-1.30	-1.06	-1.54	-1.42	-1.06	-0.93	-1.23	-2.18
Free Cash Flow Per Share TTM	-0.60	-0.63	-0.65	-0.60	-0.57	-0.51	-0.54	-0.65	-0.60	-0.74	-1.08	-2.06
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-9,949.85%	-100,350.45%	-42,639.61%	-22,922.86%	45,911.44%	24,159.13%	16,010.71%	-645.80%	-586.31%	-622.53%	-663.29%	-
Net Profit Margin TTM	-1,833.97%	-61,026.13%	-17,063.14%	-23,214.07%	93,189.05%	49,872.76%	41,448.39%	-1,198.47%	-905.38%	-687.09%	-652.20%	-
Growth Metrics
Net Revenue Growth (1Y)	-592.04%	-134.37%	-154.60%	-95.45%	-101.89%	-103.03%	-104.38%	-	-	-	-	-
Net Income Growth (1Y)	-90.32%	-57.95%	-77.52%	-11.81%	94.08%	119.93%	178.41%	45.15%	1.34%	-29.95%	-33.49%	-21.86%
EPS Growth (1Y)	-90.40%	-58.28%	-80.54%	-46.75%	21.91%	20.78%	25.21%	-34.83%	-46.35%	-52.32%	-38.12%	5.77%
Calculated Values
Free Cash Flow TTM	-86.85M	-91.78M	-94.03M	-84.31M	-81.84M	-73.24M	-67.09M	-55.17M	-54.06M	-58.73M	-60.67M	-78.09M
Net Debt	-11.95M	-30.42M	-50.76M	-79.40M	-98.87M	-122.20M	-146.48M	-49.90M	-37.46M	-35.62M	-22.92M	-16.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-16Sale

Owner: Kanter, Stacy J.

Title: -

Shares: 43,000

Price/Share: $0.11

Value: $4,730.00

Shares Owned: 65,000

Relationship: Director

Ownership: Direct

2025-03-04Sale

Owner: Perfetti, Riccardo

Title: Chief Medical Officer

Shares: 10,366

Price/Share: $0.44

Value: $4,561.04

Shares Owned: 890,409

Relationship: Officer

Ownership: Direct

2025-03-04Sale

Owner: Chinoporos, Constantine

Title: See Remarks

Shares: 447

Price/Share: $0.44

Value: $196.68

Shares Owned: 271,436

Relationship: Officer

Ownership: Direct

2025-03-04Sale

Owner: Funtleyder, Leslie D.

Title: See Remarks

Shares: 14,502

Price/Share: $0.44

Value: $6,380.88

Shares Owned: 390,459

Relationship: Director,Officer

Ownership: Direct

2025-02-06Sale

Owner: Chinoporos, Constantine

Title: See Remarks

Shares: 28,117

Price/Share: $0.61

Value: $17,151.37

Shares Owned: 271,883

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-16	Kanter, Stacy J.	Director	-	Direct	Sale	43,000	0.11	$4,730.00	65,000	4
2025-03-04	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	10,366	0.44	$4,561.04	890,409	4
2025-03-04	Chinoporos, Constantine	Officer	See Remarks	Direct	Sale	447	0.44	$196.68	271,436	4
2025-03-04	Funtleyder, Leslie D.	Director,Officer	See Remarks	Direct	Sale	14,502	0.44	$6,380.88	390,459	4
2025-02-06	Chinoporos, Constantine	Officer	See Remarks	Direct	Sale	28,117	0.61	$17,151.37	271,883	4
2025-02-06	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	86,078	0.61	$52,507.58	900,775	4
2025-02-06	Funtleyder, Leslie D.	Director,Officer	See Remarks	Direct	Sale	22,950	0.61	$13,999.50	404,961	4
2024-08-22	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	22,681	5.83	$132,230.23	986,853	4
2024-08-22	Funtleyder, Leslie D.	Director,Officer	Chief Financial Officer	Direct	Sale	13,530	5.83	$78,879.90	277,911	4
2024-08-14	Shendelman, Shoshana	Director,Officer	President and CEO	Direct	Sale	119,591	5.93	$709,174.63	4,690,839	4
2024-06-06	Shendelman, Shoshana	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	61,795	4.32	$266,954.40	3,756,019	4
2024-06-06	Funtleyder, Leslie D.	Director,Officer	Chief Financial Officer	Direct	Sale	16,980	4.32	$73,353.60	291,441	4
2024-06-06	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	22,003	4.32	$95,052.96	1,009,534	4
2024-06-05	Alexandria, Equities No. …	TenPercentOwner	-	Indirect	Sale	150,000	4.24	$636,000.00	5,855,077	4
2024-03-14	Shendelman, Shoshana	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	318,573	5.39	$1,717,108.47	3,817,814	4
2024-03-14	Hansard, Adam	Officer	Chief Commercial Officer	Direct	Sale	48,871	5.39	$263,414.69	732,919	4
2024-03-14	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	110,804	5.39	$597,233.56	1,031,537	4
2024-03-14	Funtleyder, Leslie D.	Director,Officer	Chief Financial Officer	Direct	Sale	28,727	5.39	$154,838.53	308,421	4
2023-12-01	Kanter, Stacy J.	Director	-	Direct	Purchase	30,000	2.18	$65,400.00	63,000	4
2023-11-30	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	1,583	1.97	$3,118.51	692,341	4
2023-11-30	Shendelman, Shoshana	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	3,968	1.97	$7,816.96	2,596,387	4
2023-11-30	Hansard, Adam	Officer	Chief Commercial Officer	Direct	Sale	965	1.97	$1,901.05	381,790	4
2023-11-03	Alexandria, Real Estate E…	TenPercentOwner	-	Indirect	Sale	143,450	2.31	$331,369.50	5,580,077	4
2023-11-01	Alexandria, Equities No. …	TenPercentOwner	-	Indirect	Sale	172,742	2.36	$407,671.12	5,827,335	4
2023-09-27	Hansard, Adam	Officer	Chief Commercial Officer	Direct	Sale	9,720	2.70	$26,244.00	382,755	4
2023-09-27	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	10,932	2.70	$29,516.40	693,924	4
2023-09-27	Shendelman, Shoshana	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	115,632	2.70	$312,206.40	2,600,355	4
2023-01-11	Shendelman, Shoshana	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	15,870	0.91	$14,441.70	751,625	4
2023-01-11	Hansard, Adam	Officer	Chief Commercial Officer	Direct	Sale	4,495	0.91	$4,090.45	92,475	4
2023-01-11	Perfetti, Riccardo	Officer	Chief Medical Officer	Direct	Sale	6,053	0.91	$5,508.23	154,856	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

25.06%

Inst. Shares: 36,482,594

Shares Outstanding: 145,559,604

2025-09-30

50.24%

Inst. Shares: 73,128,501

Shares Outstanding: 145,559,604

2025-06-30

47.64%

Inst. Shares: 69,120,877

Shares Outstanding: 145,091,474

2025-03-31

65.88%

Inst. Shares: 95,393,379

Shares Outstanding: 144,787,971

2024-12-31

78.12%

Inst. Shares: 109,005,317

Shares Outstanding: 139,534,746

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	36,482,594	145,559,604	25.06%
2025-09-30	73,128,501	145,559,604	50.24%
2025-06-30	69,120,877	145,091,474	47.64%
2025-03-31	95,393,379	144,787,971	65.88%
2024-12-31	109,005,317	139,534,746	78.12%
2024-09-30	111,240,999	144,345,781	77.07%
2024-06-30	103,037,077	143,934,239	71.59%
2024-03-31	93,526,980	125,318,993	74.63%
2023-12-31	60,608,600	84,244,494	71.94%
2023-09-30	42,529,906	90,669,969	46.91%
2023-06-30	30,756,530	79,041,695	38.91%
2023-03-31	18,806,924	56,357,983	33.37%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Applied Therapeutics, Inc. (APLT) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.